Month: February 2022
-
Gene Therapy Promotes Transfusion Independence for Severe Beta-Thalassemia
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.
-
Why COVID-19 Surveillance in Nigeria Is Critical
A recent Northwestern Medicine study found global efforts to track variants grossly underreported a probable variant of concern, Eta, circulating in Nigeria in early 2021.
-
Genetic Variant of High-risk Childhood Leukemia Revealed
A genetic mutation changing just one base pair of nucleotides greatly increases risk of a lethal subtype of childhood acute lymphoblastic leukemia, according to a recent study.
-
Olfactory Processing Comes in Waves
Neural waves of three distinct registers combine to give the brain a picture of what’s being smelled, according to a Northwestern Medicine study.
-
Response to Exercise is Key to Novel Device Therapy for the Most Common Type of Heart Failure
A new Northwestern Medicine study suggests that some patients with the most common type of heart failure may benefit from a novel, minimally invasive cardiac implant device called an atrial shunt.
-
Neural Stem Cell Therapy May Improve Metastatic Cancer Survival
Neural stem cells engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2 positive breast cancer brain metastases.
